Monthly Archives: May 2016

Professor Philip Morris – New Financial Transparency Arrangements Between Doctors and Drug Companies

In early 2015 the Australian Consumer and Competition Commission (ACCC) authorized a new Code of Conduct for Medicines Australia (representing the larger drug companies in Australia but not generic makers). This 18th Code Edition now includes making public all payments … Continue reading

Posted in Advocacy, Clinical Drug Trials, Media | Tagged , , , | Leave a comment

Leonard Benton – Veteran Kills Himself At the VA: A Failure Written In Blood

“It is time to speak. It is time that veterans use social media, personal demonstration, and activism to make change happen instead of waiting on it.” In every Veterans Administration job announcement, there is a copy of the VA’s mission statement. … Continue reading

Posted in Advocacy, Media | Tagged , , , , | Leave a comment

British Mefloquine Veteran Resorts to Legal Action: “They Just Put Everything Down to PTSD”

A large proportion of veterans afflicted by mefloquine toxicosis have unfortunately been misdiagnosed with post-traumatic stress disorder (PTSD). Although the symptoms of mefloquine toxicosis can be similar to PTSD, careful examination by health professionals should result in proper diagnosis and … Continue reading

Posted in Advocacy, Media, Research, Support | Tagged , , , , , , , | Leave a comment

Philippa Tuckman – Lariam for Military Personnel: An Unacceptable Risk

The House of Commons Defence Committee will publish its report An acceptable risk? The use of Lariam for military personnel  on 24thMay. Having both given evidence to the inquiry and carefully considered the submissions of other witness, I am hopeful … Continue reading

Posted in Advocacy, Support | Tagged , , , , , , , , , | Leave a comment

CDC Staff Accused Injured U.S. Veteran of “Malingering” in Response to Official Drug Regulator Safety Warning on Mefloquine

FDA Black Box Warning In 2013 the U.S. Food and Drug Administration (FDA) issued a “black box” warning regarding the safety of the anti-malarial drug mefloquine. This is the most serious warning issued by the FDA, which in this case … Continue reading

Posted in Advocacy, Media, Research, Support | Tagged , , , , , , , , , , , , , | Leave a comment

Daily Express: Ministry of Defence Accused of ‘Negligence on a Grand Scale’ As Troops Sue Over Lariam (Mefloquine)

BRITISH troops who say they were left with serious mental health side effects after taking a controversial anti-malaria drug are taking legal action against the Ministry of Defence. The group of armed forces veterans say they have suffered hallucinations, severe … Continue reading

Posted in Advocacy, Media, Support | Tagged , , , , , , , | 2 Comments

British Parliamentary Inquiry Report on the Use of Lariam™ (Mefloquine) for Military Personnel to be Published on 24 May 2016

The British Parliament’s Defence Select Committee is publishing its report, “An acceptable risk? The use of Lariam for military personnel” on Tuesday 24 May 2016 at 00.01am. Report This is the Committee’s Fourth Report of Session 2015–16 (HC 567) and it can … Continue reading

Posted in Advocacy, Clinical Drug Trials, Media, Our Stories | Tagged , , , , , , , , , , , , | 1 Comment

BBC News: Ministry of Defence Faces Legal Claims Over Malaria Drug Lariam (Mefloquine)

A group of military personnel are seeking damages from the Ministry of Defence over an anti-malarial drug they say has caused mental health problems. Law firm Irwin Mitchell says it has formally notified the MoD of several claims after being … Continue reading

Posted in Advocacy, Media, Support | Tagged , , , , , | 1 Comment

Feature Story (2004) – Veterans Affairs Alerts Doctors to Malaria Drug Concerns

WASHINGTON, June 24 (UPI) — The Department of Veterans Affairs is warning doctors to watch for long-term mental problems and other health effects from an anti-malaria drug given to soldiers in Afghanistan and Iraq. The drug is mefloquine, known by … Continue reading

Posted in Advocacy, Media, Support | Tagged , , , , , , | Leave a comment

Roche Shareholders: “Lariam Does Not Fit in with Roche’s Image”

Serious concerns over the safety of mefloquine (Lariam™) have not been limited to veterans, travellers or other consumers who have been adversely affected by the drug’s neurotoxic side effects. For many years, shareholders of the multinational Swiss manufacturer of the … Continue reading

Posted in Advocacy, Media, Research, Support | Tagged , , , , , , | Leave a comment